West Pharmaceutical Services, Inc. (WST) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Instruments & Supplies Branche. Der Hauptsitz des Unternehmens ist in Exton, PA, United States. Der aktuelle CEO ist Eric Green.
WST hat IPO-Datum 1980-03-17, 10,600 Vollzeitbeschäftigte, gelistet an der NYSE, eine Marktkapitalisierung von $19.3B.
West Pharmaceutical Services, Inc. is a leading global manufacturer of containment and delivery systems for injectable drugs and healthcare products, serving pharmaceutical, biologic, and medical device companies across the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates through two main segments: Proprietary Products, which includes stoppers, seals, syringe components, self-injection devices, and its proprietary Crystal Zenith polymer platform for vials and cartridges; and Contract-Manufactured Products, which provides design and assembly services for surgical, diagnostic, ophthalmic, and drug delivery devices. Beyond manufacturing, West offers comprehensive support services including analytical testing, regulatory expertise, engineering development, and after-sales technical support to enhance product quality and safety. Founded in 1923 and headquartered in Exton, Pennsylvania, the company distributes its products through a global network of sales representatives, distributors, and contract agents.
